| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | DRD2 OR10AG1 MRGPRE OR10K1 OR52E1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 CCR6 RXFP1 OR52N1 GPR45 GPR179 CCKAR | 2.99e-07 | 884 | 79 | 16 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TYRO3 DRD2 OR10AG1 MRGPRE OR10K1 OR52E1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 CCR6 RXFP1 OR52N1 GPR45 GPR179 CCKAR | 1.74e-05 | 1353 | 79 | 17 | GO:0004888 |
| GeneOntologyMolecularFunction | RNA transmembrane transporter activity | 4.62e-05 | 3 | 79 | 2 | GO:0051033 | |
| GeneOntologyMolecularFunction | nucleic acid transmembrane transporter activity | 4.62e-05 | 3 | 79 | 2 | GO:0051032 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR10AG1 OR10K1 OR52E1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 OR52N1 | 5.06e-05 | 431 | 79 | 9 | GO:0004984 |
| GeneOntologyMolecularFunction | acyltransferase activity, acyl groups converted into alkyl on transfer | 1.53e-04 | 5 | 79 | 2 | GO:0046912 | |
| GeneOntologyMolecularFunction | histone H4K20 methyltransferase activity | 6.81e-04 | 10 | 79 | 2 | GO:0042799 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | TYRO3 DRD2 OR10AG1 MRGPRE OR10K1 OR52E1 OR1E1 OR1E2 MFSD2B OR2W5P OR14I1 OR5A2 CCR6 RXFP1 GNAQ OR52N1 GPR45 GPR179 CCKAR | 9.32e-07 | 1395 | 79 | 19 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of smell | DRD2 OR10AG1 OR10K1 OR52E1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 OR52N1 | 1.10e-05 | 465 | 79 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR10AG1 OR10K1 OR52E1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 OR52N1 | 4.02e-05 | 432 | 79 | 9 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | DRD2 OR10AG1 OR10K1 OR52E1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 OR52N1 | 4.42e-05 | 547 | 79 | 10 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR10AG1 OR10K1 OR52E1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 GNAQ PKD1L2 OR52N1 | 9.27e-05 | 722 | 79 | 11 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR10AG1 OR10K1 OR52E1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 OR52N1 | 9.76e-05 | 485 | 79 | 9 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR10AG1 OR10K1 OR52E1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 OR52N1 | 1.75e-04 | 524 | 79 | 9 | GO:0009593 |
| Domain | GPCR_Rhodpsn_7TM | DRD2 OR10AG1 MRGPRE OR10K1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 CCR6 RXFP1 OR52N1 GPR45 CCKAR | 8.62e-07 | 670 | 80 | 14 | IPR017452 |
| Domain | 7tm_1 | DRD2 OR10AG1 MRGPRE OR10K1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 CCR6 RXFP1 OR52N1 GPR45 CCKAR | 9.75e-07 | 677 | 80 | 14 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | DRD2 OR10AG1 MRGPRE OR10K1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 CCR6 RXFP1 OR52N1 GPR45 CCKAR | 1.12e-06 | 685 | 80 | 14 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | DRD2 OR10AG1 MRGPRE OR10K1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 CCR6 RXFP1 OR52N1 GPR45 CCKAR | 1.24e-06 | 691 | 80 | 14 | PS50262 |
| Domain | GPCR_Rhodpsn | DRD2 OR10AG1 MRGPRE OR10K1 OR1E1 OR1E2 OR2W5P OR14I1 OR5A2 CCR6 RXFP1 OR52N1 GPR45 CCKAR | 1.26e-06 | 692 | 80 | 14 | IPR000276 |
| Domain | SID1_TM_fam | 1.81e-05 | 2 | 80 | 2 | IPR025958 | |
| Domain | SID-1_RNA_chan | 1.81e-05 | 2 | 80 | 2 | PF13965 | |
| Domain | Olfact_rcpt | 2.77e-04 | 393 | 80 | 8 | IPR000725 | |
| Domain | APC_su10/DOC_dom | 3.75e-04 | 7 | 80 | 2 | IPR004939 | |
| Domain | DOC | 3.75e-04 | 7 | 80 | 2 | PS51284 | |
| Domain | APC10 | 3.75e-04 | 7 | 80 | 2 | SM01337 | |
| Domain | ANAPC10 | 3.75e-04 | 7 | 80 | 2 | PF03256 | |
| Domain | ARM-type_fold | 6.23e-04 | 339 | 80 | 7 | IPR016024 | |
| Domain | ARM-like | 1.06e-03 | 270 | 80 | 6 | IPR011989 | |
| Domain | - | 2.65e-03 | 222 | 80 | 5 | 1.25.10.10 | |
| Domain | - | 3.79e-03 | 73 | 80 | 3 | 2.60.120.260 | |
| Domain | WD40_repeat_CS | 5.40e-03 | 164 | 80 | 4 | IPR019775 | |
| Domain | HECT | 5.93e-03 | 27 | 80 | 2 | PF00632 | |
| Domain | HECTc | 5.93e-03 | 27 | 80 | 2 | SM00119 | |
| Domain | HECT_dom | 5.93e-03 | 27 | 80 | 2 | IPR000569 | |
| Domain | HECT | 5.93e-03 | 27 | 80 | 2 | PS50237 | |
| Domain | Galactose-bd-like | 7.67e-03 | 94 | 80 | 3 | IPR008979 | |
| Pubmed | 1.12e-06 | 78 | 81 | 5 | 25720964 | ||
| Pubmed | Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice. | 5.36e-06 | 2 | 81 | 2 | 30076839 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28951524 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28754779 | ||
| Pubmed | Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis. | 5.36e-06 | 2 | 81 | 2 | 33036922 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 2565717 | ||
| Pubmed | Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA. | 5.36e-06 | 2 | 81 | 2 | 2917002 | |
| Pubmed | Genomic cloning and partial characterization of human chymotrypsinogen gene. | 5.36e-06 | 2 | 81 | 2 | 8186414 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 37116165 | ||
| Pubmed | A novel family of mammalian transmembrane proteins involved in cholesterol transport. | 5.36e-06 | 2 | 81 | 2 | 28785058 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26067272 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 1016231 | ||
| Pubmed | Secretagogue-induced pancreatitis in mice devoid of chymotrypsin. | 1.60e-05 | 3 | 81 | 2 | 38981616 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 33381579 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 35069527 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 1008801 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 34086670 | ||
| Pubmed | BVVL/ FL: features caused by SLC52A3 mutations; WDFY4 and TNFSF13B may be novel causative genes. | 1.60e-05 | 3 | 81 | 2 | 33189404 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 34643096 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 32678161 | ||
| Pubmed | Odorant receptors govern the formation of a precise topographic map. | 3.20e-05 | 4 | 81 | 2 | 9546391 | |
| Pubmed | Analysis of SNP profiles in patients with major depressive disorder. | 3.20e-05 | 4 | 81 | 2 | 15927089 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 25560761 | ||
| Pubmed | Genetic study of pancreatic proteinase and alpha-amylase in mice (Mus musculus). | 5.33e-05 | 5 | 81 | 2 | 4461036 | |
| Pubmed | Chromosomal assignments of genes for trypsin, chymotrypsin B, and elastase in mouse. | 5.33e-05 | 5 | 81 | 2 | 6589791 | |
| Pubmed | Allelic inactivation regulates olfactory receptor gene expression. | 5.33e-05 | 5 | 81 | 2 | 8087849 | |
| Pubmed | Genetic and biochemical characterization of a new chymotrypsin isozyme of the house mouse, CTRA-1. | 5.33e-05 | 5 | 81 | 2 | 1820020 | |
| Pubmed | The WDR11 complex facilitates the tethering of AP-1-derived vesicles. | 5.33e-05 | 5 | 81 | 2 | 29426865 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 6.55e-05 | 180 | 81 | 5 | 30110629 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 17194762 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 23814066 | ||
| Pubmed | Genome-Wide Analysis in Brazilians Reveals Highly Differentiated Native American Genome Regions. | 1.12e-04 | 7 | 81 | 2 | 28100790 | |
| Pubmed | Genetics of rheumatoid arthritis contributes to biology and drug discovery. | 1.40e-04 | 112 | 81 | 4 | 24390342 | |
| Pubmed | Mouse-human orthology relationships in an olfactory receptor gene cluster. | 1.49e-04 | 8 | 81 | 2 | 11170746 | |
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 16902085 | ||
| Pubmed | Sensitivity-dependent hierarchical receptor codes for odors. | 1.91e-04 | 9 | 81 | 2 | 12588732 | |
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 12397184 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 MYCBP2 NSD2 UBE3B WDR90 NUP188 ZZEF1 HECTD1 SIL1 SLC52A3 | 2.45e-04 | 1105 | 81 | 10 | 35748872 |
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 26361056 | ||
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 8004088 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 3.50e-04 | 400 | 81 | 6 | 35013556 | |
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 11468771 | ||
| Pubmed | Evolution of odorant receptors expressed in mammalian testes. | 4.11e-04 | 13 | 81 | 2 | 11014824 | |
| Pubmed | 4.37e-04 | 63 | 81 | 3 | 11572484 | ||
| Pubmed | 4.79e-04 | 14 | 81 | 2 | 7528109 | ||
| Pubmed | 4.79e-04 | 14 | 81 | 2 | 19902255 | ||
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 25338677 | ||
| Pubmed | Quantitative trait loci for steady-state platelet count in mice. | 5.52e-04 | 15 | 81 | 2 | 15520881 | |
| Pubmed | The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. | 6.21e-04 | 71 | 81 | 3 | 29346117 | |
| Pubmed | Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. | 6.29e-04 | 16 | 81 | 2 | 10673334 | |
| Pubmed | Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. | 6.73e-04 | 73 | 81 | 3 | 25086665 | |
| Pubmed | Olfactory receptors and signalling elements in the Grueneberg ganglion. | 7.12e-04 | 17 | 81 | 2 | 16805845 | |
| Pubmed | Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D. | 7.12e-04 | 17 | 81 | 2 | 22041458 | |
| Pubmed | 7.28e-04 | 638 | 81 | 7 | 33239621 | ||
| Pubmed | 8.29e-04 | 179 | 81 | 4 | 18577758 | ||
| Pubmed | 8.33e-04 | 653 | 81 | 7 | 22586326 | ||
| Pubmed | 8.93e-04 | 19 | 81 | 2 | 2571576 | ||
| Pubmed | 8.93e-04 | 19 | 81 | 2 | 16844427 | ||
| Pubmed | Identification of novel protein kinases expressed in the myocardium of the developing mouse heart. | 9.91e-04 | 20 | 81 | 2 | 7893599 | |
| Pubmed | 1.09e-03 | 332 | 81 | 5 | 25693804 | ||
| Pubmed | 1.09e-03 | 21 | 81 | 2 | 38320000 | ||
| Pubmed | 1.09e-03 | 21 | 81 | 2 | 24923560 | ||
| Pubmed | 1.12e-03 | 87 | 81 | 3 | 33711283 | ||
| Pubmed | 1.31e-03 | 23 | 81 | 2 | 10706615 | ||
| Pubmed | 1.31e-03 | 23 | 81 | 2 | 26124079 | ||
| Pubmed | 1.31e-03 | 23 | 81 | 2 | 14662765 | ||
| Pubmed | 1.36e-03 | 93 | 81 | 3 | 27689697 | ||
| Pubmed | Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species. | 1.43e-03 | 24 | 81 | 2 | 9119360 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.44e-03 | 95 | 81 | 3 | 29643511 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.58e-03 | 942 | 81 | 8 | 31073040 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.66e-03 | 736 | 81 | 7 | 29676528 | |
| Pubmed | 1.67e-03 | 541 | 81 | 6 | 14983052 | ||
| Pubmed | High-resolution mapping of a linkage group on mouse chromosome 8 conserved on human chromosome 16Q. | 1.68e-03 | 26 | 81 | 2 | 9069116 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 1.74e-03 | 219 | 81 | 4 | 12213199 | |
| Pubmed | ARHGAP5 DLGAP3 ATP8A1 AP1G1 SV2A ACLY SMU1 GNAQ PHGDH SACM1L | 1.78e-03 | 1431 | 81 | 10 | 37142655 | |
| Pubmed | Distribution of olfactory receptor genes in the human genome. | 1.95e-03 | 28 | 81 | 2 | 9500546 | |
| Cytoband | 18q22.3 | 3.18e-04 | 15 | 81 | 2 | 18q22.3 | |
| Cytoband | 17q21.1 | 5.72e-04 | 20 | 81 | 2 | 17q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q23 | 1.16e-03 | 116 | 81 | 3 | chr16q23 | |
| Cytoband | 16q23.1 | 1.47e-03 | 32 | 81 | 2 | 16q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.34e-03 | 346 | 81 | 4 | chr17p13 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 174 | 80 | 5 | 165e14cad57e90aa247dcecfaa3c2e8ff2a470ad | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 174 | 80 | 5 | 4289dfc7613db4bb3d706b9b65d06e84c0c53558 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-05 | 175 | 80 | 5 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-9|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-05 | 177 | 80 | 5 | ae55773c531099a9e94f44f01ba48b5e71dddc53 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 181 | 80 | 5 | d909821355f4bc9e35387cda6ecf7c56793d9da4 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 181 | 80 | 5 | 52935c496b45207a173b5ac7812f46210c3f74b0 | |
| ToppCell | control-Myeloid-CD16_Monocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.68e-05 | 195 | 80 | 5 | f398d08a23fdfa6202f73a7aeac3ff4c997fbdfd | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.75e-05 | 196 | 80 | 5 | 89a0ccd0684777927d99d5fc5b7c498f3f124250 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.75e-05 | 196 | 80 | 5 | 91a8c4798572d6c1f03cef5e8e5464ed0046c7cf | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 97 | 80 | 4 | 16947da747504c2edb9f2e7ee6f05babda0fae60 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.96e-05 | 199 | 80 | 5 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.50e-05 | 41 | 80 | 3 | b1e70962de91a747ec718a3fad4247fd0cb7d9a8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.50e-05 | 41 | 80 | 3 | 16dbb13baa47c4db80ddd83ac36aad6c43b5461a | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 144 | 80 | 4 | 5e948d4cb913ccd8f82262a1b4d20967aadab3ab | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 150 | 80 | 4 | cc8361bdcaa16ab6a0d6a3684690d709bc42ff3b | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 153 | 80 | 4 | 39ac25c48e73538f1c10f37bea386e0e88d3e8d0 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-04 | 156 | 80 | 4 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 61 | 80 | 3 | 5e855b5462f42b7a1d0bbd518cc11072342ce0cc | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 61 | 80 | 3 | 2fc13475581431f82e0b5ef42e18cd29c9787666 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 157 | 80 | 4 | a9e077f686382303f0437ebfa4f11d273ba9fe40 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-04 | 160 | 80 | 4 | 1a9329d8183296f36928bd9e96f10db9f04ce326 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 162 | 80 | 4 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 162 | 80 | 4 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.22e-04 | 165 | 80 | 4 | 83095377aedf960c05baa523869bdbd2b0a05f2d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.27e-04 | 166 | 80 | 4 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 166 | 80 | 4 | b7f303203068b205f382788815df487a0ea148ed | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 167 | 80 | 4 | 4a669eafde3582a451614ad304769b47aa1d9578 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 167 | 80 | 4 | 691f3589de0f8c13f9137812cfa9040c07d237b4 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-04 | 169 | 80 | 4 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 169 | 80 | 4 | ae85cef7ef8f761c19f4af2a23fe333641c38a92 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 169 | 80 | 4 | c01bc3f2f299109086ded83dc11e98559bf1940c | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 170 | 80 | 4 | 2491f3849e34b0ccd06015fa59d15e3d7963c76d | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-04 | 170 | 80 | 4 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-04 | 170 | 80 | 4 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-04 | 170 | 80 | 4 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 175 | 80 | 4 | 9a96794df049d8228fea57c1584c160191d36b56 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 175 | 80 | 4 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | COPD-Lymphoid-ILC_A|COPD / Disease state, Lineage and Cell class | 2.84e-04 | 176 | 80 | 4 | 484452cb38fe4604f0910a068361ed461b5b0c21 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 176 | 80 | 4 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-04 | 176 | 80 | 4 | 274458d80f9f3f080248cbf64e4784ef351e7254 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-04 | 176 | 80 | 4 | 60740f676db5d259ef3046bd5bc7b7b14924ecee | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 176 | 80 | 4 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-04 | 176 | 80 | 4 | d0a3e176df1270968efa79c00dc941c5e1c4f7aa | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 2.90e-04 | 177 | 80 | 4 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-04 | 177 | 80 | 4 | c506b8fd9a550e6cf93b64a1f7eed2543224a140 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-04 | 177 | 80 | 4 | 840eaac045ada42cae0ab81177d1d0ae55a65633 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-04 | 177 | 80 | 4 | 3535575686c9700ab72700aae6f2070ebbb50044 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-04 | 179 | 80 | 4 | dc0b806904ef4c2f74f34ade2b1c0d6893f3b2ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.03e-04 | 179 | 80 | 4 | a28a1de500a74c6dcc43481abf9ec0f7e7a300a9 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-04 | 180 | 80 | 4 | b83d067dee641941c596e4a25d81327931b6ad61 | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 3.09e-04 | 180 | 80 | 4 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 3.09e-04 | 180 | 80 | 4 | 200cecbd8c12a4ec334583fdd5057397504de71e | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.16e-04 | 181 | 80 | 4 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 3.22e-04 | 182 | 80 | 4 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 182 | 80 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-04 | 183 | 80 | 4 | 0513bb73552bfee609877d924fa97684200f595c | |
| ToppCell | IPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class | 3.29e-04 | 183 | 80 | 4 | e37d2c015c34471a8a54a0299e94b0371e1ada5a | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-04 | 183 | 80 | 4 | 6eeef55071ae25a61616df4fcfb2cea560aa7923 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-04 | 183 | 80 | 4 | 85b2335fa938a94e74251bd8d99de1bd21265ac9 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 3.36e-04 | 184 | 80 | 4 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.36e-04 | 184 | 80 | 4 | f4c9272d5cc4a70df051413b5c60ca6d1d80eb84 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 184 | 80 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | 98bb853c495eb16c3663685a8e20755bd309b520 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 3.43e-04 | 185 | 80 | 4 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 3.43e-04 | 185 | 80 | 4 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.50e-04 | 186 | 80 | 4 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | (1)_B_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.50e-04 | 186 | 80 | 4 | fe0f8e99ca766e004c351835fdbc2dc888dceb62 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-04 | 187 | 80 | 4 | 57f9c9162694c184a8fd6634ee0fad511ca71c9e | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-B_cell-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-04 | 187 | 80 | 4 | 6ce6d3678026101c4397320430433c9f05740883 | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 3.57e-04 | 187 | 80 | 4 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.64e-04 | 188 | 80 | 4 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 188 | 80 | 4 | a7158b5c94e6b356877f016e52f2c24a3f5d24d2 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 3.79e-04 | 190 | 80 | 4 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | severe-B_naive|World / disease stage, cell group and cell class | 3.79e-04 | 190 | 80 | 4 | 8dfe067d75573289299a5fba42b6c9b26e5fb430 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 190 | 80 | 4 | ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2 | |
| ToppCell | severe-B_naive|severe / disease stage, cell group and cell class | 3.79e-04 | 190 | 80 | 4 | 2430a1fd18385305bf1b604747ff64026a8d5edf | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|B_cell_maturation / Lineage and Cell class | 3.87e-04 | 191 | 80 | 4 | 4ee160a863d4fb9c4c9449633b9f337db8871992 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-04 | 191 | 80 | 4 | 8c35fccc4617694eae1e55b1107841ffe7f1bac8 | |
| ToppCell | Control-Lymphoid-ILC_A|Control / Disease state, Lineage and Cell class | 3.87e-04 | 191 | 80 | 4 | 1ca73582dc3d28322b5ee841010067589d848acc | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.87e-04 | 191 | 80 | 4 | b7d17d3ba488378b30f3732f8109f4a7c1673e61 | |
| ToppCell | critical-Lymphoid-B_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.87e-04 | 191 | 80 | 4 | 0716cfaeb11d9c90c18fa8f9d50c9c6fb5182848 | |
| ToppCell | CV-Mild-5|CV / Virus stimulation, Condition and Cluster | 3.87e-04 | 191 | 80 | 4 | cf40d2b3daeb968b05b4dc2a0a9dc3eb9a0cccfa | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.87e-04 | 191 | 80 | 4 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | Ciliated-cil-3|World / Class top | 3.95e-04 | 192 | 80 | 4 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.02e-04 | 193 | 80 | 4 | 437ae3b10d169bb371f7b92d57a77f43e3f8d64d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.02e-04 | 193 | 80 | 4 | 00349d176fb6a46cbcc99c41d975651b6e9aaad4 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 4.02e-04 | 193 | 80 | 4 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.02e-04 | 193 | 80 | 4 | 94b5a4a4e9faaa95cb72907a2f0497429c72e516 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.02e-04 | 193 | 80 | 4 | 2416b39e18ce0c7016c2351f79bf1b2ecc183a98 | |
| ToppCell | severe-Myeloid-CD16_Monocytes|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.10e-04 | 194 | 80 | 4 | 1b33248b8a7cb914783bcf9e6a80481b4db7e0e8 | |
| ToppCell | severe_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 4.10e-04 | 194 | 80 | 4 | cb346cb186fe80a8f490ae90b2539b3543ba0ca9 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.10e-04 | 194 | 80 | 4 | 1b4a17d58793e8889484fe592dce8ee1e8fe77a9 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.10e-04 | 194 | 80 | 4 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.10e-04 | 194 | 80 | 4 | 9a99abc65e7509e7ae8fb392f5ee4b2a83128072 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.10e-04 | 194 | 80 | 4 | 87604c93d20f9171e0a1279bdb6ad73fe5fed356 | |
| ToppCell | Control-Lymphoid|Control / Disease state, Lineage and Cell class | 4.10e-04 | 194 | 80 | 4 | d5b124f15c953eeb7e8e990df44d7fa466f2b31f | |
| ToppCell | COVID-19_Convalescent-Lymphoid_B-B_intermediate|COVID-19_Convalescent / Disease group, lineage and cell class | 4.18e-04 | 195 | 80 | 4 | b213f19dad4c8d5a6bf20cadb1135fb2bb0b40ee | |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 4.18e-04 | 195 | 80 | 4 | 72928a1d987a3a5361c666f3972292aefec5f548 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.18e-04 | 195 | 80 | 4 | 1ce4c9ab82212f399ddba9784d2bcec70b6b98b2 | |
| Drug | Pd-Ti | 1.16e-05 | 13 | 80 | 3 | CID006452040 | |
| Drug | c189 | 1.22e-05 | 2 | 80 | 2 | CID000248048 | |
| Drug | BOCPheONP | 1.22e-05 | 2 | 80 | 2 | CID000111308 | |
| Drug | dansyl-D-arginine methyl ester | 1.22e-05 | 2 | 80 | 2 | CID000191369 | |
| Drug | MPM-06 | 1.22e-05 | 2 | 80 | 2 | CID000161546 | |
| Drug | methyl 6-phenylhexanoate | 1.22e-05 | 2 | 80 | 2 | CID011820300 | |
| Drug | NSC-374899 | 1.22e-05 | 2 | 80 | 2 | CID000435726 | |
| Drug | 5-aminotetrazole | 1.22e-05 | 2 | 80 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 1.22e-05 | 2 | 80 | 2 | CID000074924 | |
| Drug | p-toluamidine | 1.22e-05 | 2 | 80 | 2 | CID000122753 | |
| Drug | methylbenzenebutanoate | 1.22e-05 | 2 | 80 | 2 | CID000281254 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 1.22e-05 | 2 | 80 | 2 | CID000191275 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 1.22e-05 | 2 | 80 | 2 | CID004418081 | |
| Drug | songorine | 1.22e-05 | 2 | 80 | 2 | CID000120706 | |
| Drug | isobutyl sulfide | 1.22e-05 | 2 | 80 | 2 | CID000011607 | |
| Drug | fluorescein dilaurate | 1.48e-05 | 14 | 80 | 3 | CID000081743 | |
| Drug | CCK-9 | 2.26e-05 | 16 | 80 | 3 | CID000163781 | |
| Drug | De 1 | 2.74e-05 | 17 | 80 | 3 | CID006453604 | |
| Drug | glutamol-AMP | 3.28e-05 | 18 | 80 | 3 | CID005288456 | |
| Drug | 3-amino-2-pyridone | 3.65e-05 | 3 | 80 | 2 | CID000322353 | |
| Drug | ASA-BMPA | 3.65e-05 | 3 | 80 | 2 | CID003035649 | |
| Drug | p-nitrophenyl benzoate | 3.65e-05 | 3 | 80 | 2 | CID000070396 | |
| Drug | N-acetylbenzotriazole | 3.65e-05 | 3 | 80 | 2 | CID000087784 | |
| Drug | Z-Phe-OMe | 3.65e-05 | 3 | 80 | 2 | CID003082435 | |
| Drug | photophor | 3.65e-05 | 3 | 80 | 2 | CID000014780 | |
| Drug | 3-methylcoumarin | 3.65e-05 | 3 | 80 | 2 | CID000017130 | |
| Drug | dibutyl iodomethaneboronate | 3.65e-05 | 3 | 80 | 2 | CID000098591 | |
| Drug | zinc;dipicolinate | 3.65e-05 | 3 | 80 | 2 | CID004309911 | |
| Drug | 2-propyl methylphosphonochloridate | 3.65e-05 | 3 | 80 | 2 | CID000102124 | |
| Drug | 2-oxobut-3-ynoate | 3.65e-05 | 3 | 80 | 2 | CID000171547 | |
| Drug | AFMeq | 3.65e-05 | 3 | 80 | 2 | CID000194069 | |
| Drug | Bz-Cti-otbu | 3.65e-05 | 3 | 80 | 2 | CID006452691 | |
| Drug | n-(2-oxoethyl)benzamide | 3.65e-05 | 3 | 80 | 2 | CID000188995 | |
| Drug | AC1L49DM | 3.65e-05 | 3 | 80 | 2 | CID000152933 | |
| Drug | FK-316 | 3.65e-05 | 3 | 80 | 2 | CID000133688 | |
| Drug | AC1L19T8 | 3.65e-05 | 3 | 80 | 2 | CID000000694 | |
| Drug | Marinostatin D | 3.65e-05 | 3 | 80 | 2 | CID000132206 | |
| Drug | c140 | 3.65e-05 | 3 | 80 | 2 | CID002783250 | |
| Drug | 1FD7 | 3.65e-05 | 3 | 80 | 2 | CID000445579 | |
| Drug | Benzamidomethaneboronic acid | 3.65e-05 | 3 | 80 | 2 | CID000127677 | |
| Drug | phenyl hippurate | 3.65e-05 | 3 | 80 | 2 | CID000076323 | |
| Drug | FK-386 | 3.65e-05 | 3 | 80 | 2 | CID000135044 | |
| Drug | FK-375 | 3.65e-05 | 3 | 80 | 2 | CID000135042 | |
| Drug | carbostyril-124 | 3.65e-05 | 3 | 80 | 2 | CID000088277 | |
| Drug | N-trifluoroacetyl-4-fluorophenylalanine | 3.65e-05 | 3 | 80 | 2 | CID000328214 | |
| Drug | Glt-leu-phe-nh-meq | 3.65e-05 | 3 | 80 | 2 | CID000194914 | |
| Drug | AC1L4Z4F | 3.65e-05 | 3 | 80 | 2 | CID000194913 | |
| Drug | Glt-Phe-NH-FMeq | 3.65e-05 | 3 | 80 | 2 | CID000194912 | |
| Drug | C18 4 | 3.65e-05 | 3 | 80 | 2 | CID000077248 | |
| Drug | diacetyl trimer | 3.65e-05 | 3 | 80 | 2 | CID000193527 | |
| Drug | FK-448 | 3.65e-05 | 3 | 80 | 2 | CID006917869 | |
| Drug | Ac-Phe-OMe | 3.65e-05 | 3 | 80 | 2 | CID000097805 | |
| Drug | taraxastane | 3.65e-05 | 3 | 80 | 2 | CID006429404 | |
| Drug | thiobenzyl N-heptafluorobutyrylanthranilate | 3.65e-05 | 3 | 80 | 2 | CID000133906 | |
| Drug | Phe-phe-ome | 3.65e-05 | 3 | 80 | 2 | CID000151728 | |
| Drug | phenylethaneboronic acid | 3.65e-05 | 3 | 80 | 2 | CID000065389 | |
| Drug | AC1MREQX | 4.56e-05 | 20 | 80 | 3 | CID003491744 | |
| Drug | Benzoyl-dl-leucine | 7.28e-05 | 4 | 80 | 2 | CID000294887 | |
| Drug | Acafcek | 7.28e-05 | 4 | 80 | 2 | CID000197677 | |
| Drug | p-fluorobenzenesulfonyl chloride | 7.28e-05 | 4 | 80 | 2 | CID000009588 | |
| Drug | BSSDA | 7.28e-05 | 4 | 80 | 2 | CID003081106 | |
| Drug | B-1,3-od | 7.28e-05 | 4 | 80 | 2 | CID011971053 | |
| Drug | AC1L2HV6 | 7.28e-05 | 4 | 80 | 2 | CID000047328 | |
| Drug | dehydromerodesmosine | 7.28e-05 | 4 | 80 | 2 | CID006443540 | |
| Drug | AC1L4X1Z | 7.28e-05 | 4 | 80 | 2 | CID000193815 | |
| Drug | alpha-amyrin palmitate | 7.28e-05 | 4 | 80 | 2 | CID000185477 | |
| Drug | poly-THIQ | 7.28e-05 | 4 | 80 | 2 | CID006453487 | |
| Drug | NSC-676827 | 7.28e-05 | 4 | 80 | 2 | CID000385555 | |
| Drug | N-(4-carboxycyclohexylmethyl)-maleimide | 7.28e-05 | 4 | 80 | 2 | CID011548799 | |
| Drug | G2505_sigma | 7.28e-05 | 4 | 80 | 2 | CID000111098 | |
| Drug | 6-amino-1,2-benzopyrone | 7.28e-05 | 4 | 80 | 2 | CID000046152 | |
| Drug | nitrophenylethanol | 7.28e-05 | 4 | 80 | 2 | CID000097851 | |
| Drug | dialuminum | 9.09e-05 | 25 | 80 | 3 | CID006857644 | |
| Drug | A-C-A | 9.15e-05 | 67 | 80 | 4 | CID015955872 | |
| Drug | benzoylphenylalanine | 1.15e-04 | 71 | 80 | 4 | CID000097370 | |
| Drug | AC1L9M3D | 1.15e-04 | 27 | 80 | 3 | CID000448563 | |
| Drug | 7-chloro-4-nitrobenzofuran | 1.21e-04 | 5 | 80 | 2 | CID000130782 | |
| Drug | ascididemin | 1.21e-04 | 5 | 80 | 2 | CID000189219 | |
| Drug | Ac-Trp-OEt | 1.21e-04 | 5 | 80 | 2 | CID000304749 | |
| Drug | Z-Phe-Leu | 1.21e-04 | 5 | 80 | 2 | CID000333351 | |
| Drug | 5'-FSBAzA | 1.21e-04 | 5 | 80 | 2 | CID000130430 | |
| Drug | AC1L3F57 | 1.21e-04 | 5 | 80 | 2 | CID000139565 | |
| Drug | apne | 1.21e-04 | 5 | 80 | 2 | CID000098192 | |
| Drug | 3,5-dimethylpyrazole-1-carboxamidine | 1.21e-04 | 5 | 80 | 2 | CID000097525 | |
| Drug | Maap-borov | 1.21e-04 | 5 | 80 | 2 | CID005486914 | |
| Drug | 2-amino-4,6-dichlorotriazine | 1.21e-04 | 5 | 80 | 2 | CID000013615 | |
| Drug | AC1O52A0 | 1.21e-04 | 5 | 80 | 2 | CID006475891 | |
| Drug | allysine aldol | 1.21e-04 | 5 | 80 | 2 | CID000191270 | |
| Drug | L-741,626 | 1.28e-04 | 28 | 80 | 3 | CID000133633 | |
| Drug | octyl isocyanate | 1.81e-04 | 6 | 80 | 2 | CID000076616 | |
| Drug | Asp-Asp-Asp-Asp | 1.81e-04 | 6 | 80 | 2 | CID004432006 | |
| Drug | N-benzoyl-L-tyrosine thiobenzyl ester | 1.81e-04 | 6 | 80 | 2 | CID000191444 | |
| Drug | Leupeptin acid | 1.81e-04 | 6 | 80 | 2 | CID000189069 | |
| Drug | Sri 8835 | 1.81e-04 | 6 | 80 | 2 | CID000479975 | |
| Drug | N,N-dimethylglycylbenzocaine | 1.81e-04 | 6 | 80 | 2 | CID000188251 | |
| Drug | FSH l | 1.81e-04 | 6 | 80 | 2 | CID000472883 | |
| Drug | N-benzoyltyrosine butylamide | 1.81e-04 | 6 | 80 | 2 | CID000125261 | |
| Drug | D-gluconyl-glycine azide | 1.81e-04 | 6 | 80 | 2 | CID000194550 | |
| Drug | 2-azidoatrazine | 1.81e-04 | 6 | 80 | 2 | CID003032432 | |
| Drug | L-659,286 | 1.81e-04 | 6 | 80 | 2 | CID000128954 | |
| Disease | level of chymotrypsinogen B2 in blood serum | 7.08e-06 | 2 | 79 | 2 | OBA_2041192 | |
| Disease | chymotrypsinogen B measurement | 2.12e-05 | 3 | 79 | 2 | EFO_0801477 | |
| Disease | guilt measurement | 1.70e-04 | 40 | 79 | 3 | EFO_0009595 | |
| Disease | trypsin-2 measurement | 3.83e-04 | 11 | 79 | 2 | EFO_0008305 | |
| Disease | unipolar depression, mood disorder | 4.69e-04 | 134 | 79 | 4 | EFO_0003761, EFO_0004247 | |
| Disease | Paranoid Schizophrenia | 5.42e-04 | 13 | 79 | 2 | C0036349 | |
| Disease | Schizophrenia | 5.84e-04 | 883 | 79 | 9 | C0036341 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.14e-03 | 170 | 79 | 4 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | alcohol consumption measurement | 1.73e-03 | 1242 | 79 | 10 | EFO_0007878 | |
| Disease | Anhedonia | 1.88e-03 | 24 | 79 | 2 | C0178417 | |
| Disease | digestive system infectious disorder | 2.21e-03 | 26 | 79 | 2 | MONDO_0043424 | |
| Disease | myeloperoxidase measurement | 2.21e-03 | 26 | 79 | 2 | EFO_0005243 | |
| Disease | HbA1c measurement | 2.22e-03 | 675 | 79 | 7 | EFO_0004541 | |
| Disease | neurotic disorder | 2.55e-03 | 101 | 79 | 3 | EFO_0004257 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVMICAGASGVSSCM | 196 | Q6GPI1 | |
| PVFMALAFCLCMAEA | 56 | Q8N8Q1 | |
| LRMLLVAMEAQGCSC | 451 | P43353 | |
| CGMLLLTCISMDRYI | 131 | P51684 | |
| EVACARMVGSCCTIM | 476 | Q9H211 | |
| LSLAVSDLMLCLFCM | 81 | P32238 | |
| AVSSCILAMVCGSQM | 441 | O75129 | |
| IICEFLTMMAVCHTA | 476 | Q9Y2Q0 | |
| AMLLFISGMIFCTSC | 171 | P56880 | |
| MGFCTDREDINSLCM | 56 | Q01581 | |
| GADLMALCREAAMCA | 471 | O15381 | |
| MTLESIMACCLSEEA | 1 | P50148 | |
| LALCTLGCMGSSEMC | 121 | O43747 | |
| CLTQMFFIHLCTGME | 96 | Q8NGJ3 | |
| CLAMCEEMLGALLSR | 396 | P51606 | |
| LSTIVCALATAMCCM | 186 | O60320 | |
| QMCFFLMLGGTECLL | 91 | Q8NH19 | |
| CGIVCLMMLAAAIYG | 296 | Q9HBL6 | |
| CMCFGLAFMLAGVIL | 56 | Q9Y287 | |
| ACQACCMLAIFLSML | 386 | Q6PRD1 | |
| GMCDFMNLSLADCLL | 101 | Q02083 | |
| SACGMERLLDICAAM | 331 | O95671 | |
| HFLCEMPALIAMSCE | 176 | A6NFC9 | |
| CGMGLTECFLLAAMA | 106 | Q8NGI9 | |
| MSCLMVERCGEILFE | 1 | Q9NP56 | |
| CGFDSECLNRMLMFE | 1026 | O96028 | |
| TCMILAGLCILMVGS | 466 | A6NFX1 | |
| AAVLGCCMEELISRM | 101 | Q86WI0 | |
| ALLCCTMCGASLMLL | 186 | Q86SM8 | |
| LAFSDIMLSLCCMPF | 76 | Q9Y5Y3 | |
| CFSLLLCTMLTSIMF | 1556 | Q7Z442 | |
| ATMLVLAMDCGVNCF | 171 | P09467 | |
| MSFVLSRMAACGGTC | 1 | Q8N9I9 | |
| LCMLLLMSDNVDRCF | 31 | Q9ULT8 | |
| ALEAMFTAMCECQAL | 121 | P54105 | |
| FDGCIKSCSMMDVTL | 416 | Q8NCQ5 | |
| RCLACTGMSMSLDGQ | 311 | O95886 | |
| LMDHSNMDCFICCIL | 301 | Q14790 | |
| HCDIFVTLDVMMCTA | 106 | P14416 | |
| MDFLMSGLAACGACV | 1 | Q3KQZ1 | |
| LESFLIVAMCCTCTM | 151 | Q9Y666 | |
| GMLLLCFMCCTTLLS | 121 | Q9UKG4 | |
| AFSMCIICLLMAGDT | 531 | Q9NTJ5 | |
| DVMICAGASGVSSCM | 196 | P17538 | |
| MLHTLLMARLCFCAD | 166 | P47887 | |
| AMLHTLLMARLCFCA | 156 | P30953 | |
| CMGLMAAACACGFTV | 141 | Q8NGX5 | |
| SSCLVLGCFILMMIS | 201 | A6ND48 | |
| VLMLMALDHCVAICF | 116 | Q8NH53 | |
| LVFFLLLSIMMACCL | 221 | Q9NQ40 | |
| LLSIMMACCLVAFFV | 226 | Q9NQ40 | |
| ALMMEGLLSACYHVC | 556 | Q8NBJ9 | |
| LTCNSMVLFDHMGCL | 1016 | Q02880 | |
| GLCVIFLSCTMMPNF | 506 | A0AVI2 | |
| ELCGLSSVANLMQCM | 946 | Q9UPR0 | |
| ALLDIMDMFCDRLSC | 96 | O75448 | |
| CEMEDLMPCSLGTFV | 766 | A0A0B4J2F2 | |
| CEMEDLMPCSLGTFV | 766 | P57059 | |
| MLLGLLMAACFTFCL | 16 | Q9H173 | |
| DMCMICFTEALSAAP | 4426 | O75592 | |
| VMCAMCGDPFSVDLI | 781 | Q13017 | |
| FTVAMCSGCEMLLII | 401 | Q5PT55 | |
| SLMCFTVLCEAMDGN | 586 | Q9NRP7 | |
| RMLAGSSVMSCVSCF | 626 | Q7L0J3 | |
| SCQFIEMCLMVTADH | 886 | P53396 | |
| LLLRCMVVGSCTDGM | 56 | Q5JXA9 | |
| AECMLRLVDCAMGTA | 1696 | Q96KV7 | |
| AVLCMCFSRDTEMLA | 266 | Q2TAY7 | |
| GCIILDMTSCSFMDG | 221 | Q8NE28 | |
| ALMMEGVLSACYHVC | 551 | Q9NXL6 | |
| VMCEAGLLGTLMASC | 876 | Q6ZS81 | |
| LICQDMDCLMLTFGD | 301 | Q5SRE5 | |
| AMSIISLCCADCLMG | 441 | Q9HBX9 | |
| SAESMVEYGTCMCLV | 211 | O43609 | |
| MSHLLEMCVSGDLVC | 316 | Q8N4Q0 | |
| LAMLMLFCDCSRHLI | 526 | Q7Z3V4 | |
| EVMLETCGLLMSLGC | 36 | Q08ER8 | |
| MACRCLSFLLMGTFL | 1 | Q9UKI3 | |
| CREDMLGTMALAACQ | 2676 | O43149 | |
| AAELTCGMIMCLARQ | 106 | O43175 | |
| GCIRVLEMSMKSACF | 816 | Q9BZH6 | |
| MAASMCDVFSFCVGV | 1 | Q6GMV2 | |
| CMLAEDMTVCVADFG | 661 | Q06418 | |
| CLGVLAMAEAMQCSE | 436 | Q96CT2 |